• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿路上皮癌中微卫星不稳定性的形态学预测因子。

Morphological predictors for microsatellite instability in urothelial carcinoma.

机构信息

Hospital Universitario del Tajo, Aranjuez, Madrid, Spain.

Hospital Universitario de Móstoles, Móstoles, Madrid, Spain.

出版信息

Diagn Pathol. 2021 Nov 20;16(1):106. doi: 10.1186/s13000-021-01168-2.

DOI:10.1186/s13000-021-01168-2
PMID:34801034
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8606048/
Abstract

INTRODUCTION

Microsatellite instability occurs due to a series of mutations in the DNA pairing error repair (Mismatch repair; MMR) genes, which can affect germ cells as occurs in Lynch syndrome, whose patients are at high risk of developing multiple cancers. The loss of MMR protein is commonly determined by immunohistochemical studies. Although the relation between microsatellite instability and urothelial carcinomas has been widely studied, its evaluation is not currently performed in the analysis of urothelial carcinomas.

METHODS

In this study, the microsatellite status of 139 urothelial carcinomas was analyzed and their clinicopathological characteristics were evaluated. We identified that 10.3% (13 patients) of urothelial carcinomas had loss of MMR protein expression (9 MLH1; 5 MSH2; 2 PMS2; 2 PSH6; n = 139).

RESULTS

Results suggest that these tumors occur more frequently in males, are more frequently located in the bladder or ureters, and present a high tumor grade with a papillary histological pattern that does not infiltrate the lamina propria or, in the case of infiltrating tumors, that grows into perivesical tissues.

CONCLUSIONS

We identified patients with the aforementioned tumor characteristics as patients with a high probability of presenting loss of MMR protein expression, and consider that only these patients should undergo further immunohistochemical and molecular techniques for proper diagnosis. Therefore, we propose that the clinicopathological characteristics found in the present study could become possible markers to determine which cases should undergo additional tests.

摘要

简介

微卫星不稳定性是由于 DNA 配对错误修复(错配修复;MMR)基因的一系列突变引起的,这种突变可影响生殖细胞,就像林奇综合征那样,其患者发生多种癌症的风险很高。MMR 蛋白的缺失通常通过免疫组织化学研究来确定。尽管微卫星不稳定性与尿路上皮癌之间的关系已被广泛研究,但目前在分析尿路上皮癌时并未进行其评估。

方法

在这项研究中,分析了 139 例尿路上皮癌的微卫星状态,并评估了其临床病理特征。我们发现,10.3%(13 例患者)的尿路上皮癌存在 MMR 蛋白表达缺失(9 例 MLH1;5 例 MSH2;2 例 PMS2;2 例 PSH6;n=139)。

结果

结果表明,这些肿瘤更常发生于男性,更常位于膀胱或输尿管,且具有高肿瘤分级、乳头状组织学模式,未浸润固有层,或在浸润性肿瘤的情况下,生长至膀胱周围组织。

结论

我们将具有上述肿瘤特征的患者鉴定为存在 MMR 蛋白表达缺失的高概率患者,并且认为只有这些患者应进一步进行免疫组织化学和分子技术检查以做出正确诊断。因此,我们提出,本研究中发现的临床病理特征可能成为确定哪些病例应进行额外检查的潜在标志物。

相似文献

1
Morphological predictors for microsatellite instability in urothelial carcinoma.尿路上皮癌中微卫星不稳定性的形态学预测因子。
Diagn Pathol. 2021 Nov 20;16(1):106. doi: 10.1186/s13000-021-01168-2.
2
Universal Lynch Syndrome Screening Should be Performed in All Upper Tract Urothelial Carcinomas.所有上尿路尿路上皮癌均应进行普遍林奇综合征筛查。
Am J Surg Pathol. 2018 Nov;42(11):1549-1555. doi: 10.1097/PAS.0000000000001141.
3
Clinicopathological characteristics of patients with upper urinary tract urothelial cancer with loss of immunohistochemical expression of the DNA mismatch repair proteins in universal screening.在全面筛查中DNA错配修复蛋白免疫组化表达缺失的上尿路尿路上皮癌患者的临床病理特征
Int J Urol. 2018 Feb;25(2):151-156. doi: 10.1111/iju.13481. Epub 2017 Nov 22.
4
High-level microsatellite instability in appendiceal carcinomas.阑尾腺癌中高水平微卫星不稳定。
Am J Surg Pathol. 2013 Aug;37(8):1192-200. doi: 10.1097/PAS.0b013e318282649b.
5
Upper tract urothelial carcinomas: frequency of association with mismatch repair protein loss and lynch syndrome.上尿路尿路上皮癌:与错配修复蛋白缺失及林奇综合征的关联频率
Mod Pathol. 2017 Jan;30(1):146-156. doi: 10.1038/modpathol.2016.171. Epub 2016 Oct 7.
6
Immunohistochemical null-phenotype for mismatch repair proteins in colonic carcinoma associated with concurrent MLH1 hypermethylation and MSH2 somatic mutations.在伴有MLH1高甲基化和MSH2体细胞突变的结肠癌中错配修复蛋白的免疫组化无表型。
Fam Cancer. 2018 Apr;17(2):225-228. doi: 10.1007/s10689-017-0031-9.
7
Urinary Tract Cancer in Lynch Syndrome; Increased Risk in Carriers of MSH2 Mutations.林奇综合征中的泌尿系统癌症;MSH2突变携带者的风险增加。
Urology. 2015 Dec;86(6):1212-7. doi: 10.1016/j.urology.2015.08.018. Epub 2015 Sep 15.
8
Germline MLH1 Mutations Are Frequently Identified in Lynch Syndrome Patients With Colorectal and Endometrial Carcinoma Demonstrating Isolated Loss of PMS2 Immunohistochemical Expression.在林奇综合征患者中,结直肠癌和子宫内膜癌患者若显示PMS2免疫组化表达单独缺失,则常可检测到胚系MLH1突变。
Am J Surg Pathol. 2015 Aug;39(8):1114-20. doi: 10.1097/PAS.0000000000000425.
9
Clinicopathologic Comparison of Lynch Syndrome-associated and "Lynch-like" Endometrial Carcinomas Identified on Universal Screening Using Mismatch Repair Protein Immunohistochemistry.使用错配修复蛋白免疫组织化学在普遍筛查中鉴定的林奇综合征相关和“林奇样”子宫内膜癌的临床病理比较
Am J Surg Pathol. 2016 Feb;40(2):155-65. doi: 10.1097/PAS.0000000000000544.
10
Ovarian endometrioid adenocarcinoma: incidence and clinical significance of the morphologic and immunohistochemical markers of mismatch repair protein defects and tumor microsatellite instability.卵巢子宫内膜样腺癌:错配修复蛋白缺陷和肿瘤微卫星不稳定性的形态和免疫组织化学标志物的发生率和临床意义。
Am J Surg Pathol. 2012 Feb;36(2):163-72. doi: 10.1097/PAS.0b013e31823bc434.

引用本文的文献

1
The Evolving Molecular Landscape and Actionable Alterations in Urologic Cancers.泌尿系统肿瘤的不断变化的分子谱和可操作的改变。
Curr Oncol. 2024 Nov 6;31(11):6909-6937. doi: 10.3390/curroncol31110511.
2
Mismatch repair deficiency and microsatellite instability in urothelial carcinoma: a systematic review and meta-analysis.尿路上皮癌中的错配修复缺陷与微卫星不稳定性:一项系统评价与荟萃分析
BMJ Oncol. 2024 Jan;3(1). doi: 10.1136/bmjonc-2024-000335. Epub 2024 Apr 30.
3
Targeted therapies in bladder cancer: signaling pathways, applications, and challenges.

本文引用的文献

1
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
2
Lynch Syndrome: Its Impact on Urothelial Carcinoma.林奇综合征:对尿路上皮癌的影响。
Int J Mol Sci. 2021 Jan 7;22(2):531. doi: 10.3390/ijms22020531.
3
MMR deficiency in urothelial carcinoma of the bladder presents with temporal and spatial homogeneity throughout the tumor mass.
膀胱癌的靶向治疗:信号通路、应用及挑战
MedComm (2020). 2023 Dec 15;4(6):e455. doi: 10.1002/mco2.455. eCollection 2023 Dec.
4
Clinicopathological characteristics, molecular landscape, and biomarker landscape for predicting the efficacy of PD-1/PD-L1 inhibitors in Chinese population with mismatch repair deficient urothelial carcinoma: a real-world study.中国人群中错配修复缺陷型尿路上皮癌的临床病理特征、分子谱和生物标志物谱与 PD-1/PD-L1 抑制剂疗效预测的相关性:一项真实世界研究。
Front Immunol. 2023 Nov 6;14:1269097. doi: 10.3389/fimmu.2023.1269097. eCollection 2023.
5
Cross-species oncogenomics offers insight into human muscle-invasive bladder cancer.种间致癌基因组学为研究人类肌肉浸润性膀胱癌提供了新视角。
Genome Biol. 2023 Aug 28;24(1):191. doi: 10.1186/s13059-023-03026-4.
6
Microsatellite Instability: A Review of Molecular Epidemiology and Implications for Immune Checkpoint Inhibitor Therapy.微卫星不稳定性:分子流行病学综述及其对免疫检查点抑制剂治疗的意义
Cancers (Basel). 2023 Apr 13;15(8):2288. doi: 10.3390/cancers15082288.
膀胱尿路上皮癌存在 MMR 缺陷,表现为肿瘤组织在时间和空间上具有均一性。
Urol Oncol. 2020 May;38(5):488-495. doi: 10.1016/j.urolonc.2019.12.012. Epub 2020 Feb 14.
4
Microsatellite Instability in Endometrial Carcinoma by Immunohistochemistry, Association with Clinical and Histopathologic Parameters.子宫内膜癌中微卫星不稳定性的免疫组织化学检测及其与临床和组织病理学参数的相关性
Asian Pac J Cancer Prev. 2019 Sep 1;20(9):2601-2606. doi: 10.31557/APJCP.2019.20.9.2601.
5
Clinical characteristics of patients with colorectal cancer with double somatic mismatch repair mutations compared with Lynch syndrome.与林奇综合征相比,具有双重体细胞错配修复突变的结直肠癌患者的临床特征。
J Med Genet. 2019 Jul;56(7):462-470. doi: 10.1136/jmedgenet-2018-105698. Epub 2019 Mar 15.
6
Universal Lynch Syndrome Screening Should be Performed in All Upper Tract Urothelial Carcinomas.所有上尿路尿路上皮癌均应进行普遍林奇综合征筛查。
Am J Surg Pathol. 2018 Nov;42(11):1549-1555. doi: 10.1097/PAS.0000000000001141.
7
Molecular subtype classification of urothelial carcinoma in Lynch syndrome.林奇综合征中尿路上皮癌的分子亚型分类。
Mol Oncol. 2018 Aug;12(8):1286-1295. doi: 10.1002/1878-0261.12325. Epub 2018 Jun 19.
8
Clinicopathological characteristics of patients with upper urinary tract urothelial cancer with loss of immunohistochemical expression of the DNA mismatch repair proteins in universal screening.在全面筛查中DNA错配修复蛋白免疫组化表达缺失的上尿路尿路上皮癌患者的临床病理特征
Int J Urol. 2018 Feb;25(2):151-156. doi: 10.1111/iju.13481. Epub 2017 Nov 22.
9
Universal Point of Care Testing for Lynch Syndrome in Patients with Upper Tract Urothelial Carcinoma.上尿路尿路上皮癌患者林奇综合征的通用即时检测
J Urol. 2018 Jan;199(1):60-65. doi: 10.1016/j.juro.2017.08.002. Epub 2017 Aug 7.
10
Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study.纳武利尤单抗治疗转移性DNA错配修复缺陷或微卫星高度不稳定结直肠癌患者(CheckMate 142):一项开放标签、多中心、2期研究。
Lancet Oncol. 2017 Sep;18(9):1182-1191. doi: 10.1016/S1470-2045(17)30422-9. Epub 2017 Jul 19.